We are live on ! Find out more
GPCR icon

Structure Therapeutics
GPCR

84 hedge funds and large institutions have $1.64B invested in Structure Therapeutics in 2023 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 29 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 6

383% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 6

175% more funds holding in top 10

Funds holding in top 10: 4 → 11 (+7)

135% more capital invested

Capital invested by funds: $699M → $1.64B (+$944M)

75% more funds holding

Funds holding: 48 → 84 (+36)

14.1% more ownership

Funds ownership: 16.43% → 30.53% (+14%)

Holders
84
Holders Change
+36
Holders Change %
+75%
% of All Funds
1.33%
Holding in Top 10
11
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+175%
% of All Funds
0.17%
New
42
Increased
29
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$64.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$51.8M
3
DCM
Driehaus Capital Management
Illinois
+$40.4M
4
TCM
TCG Crossover Management
California
+$37.1M
5
HH
HSG Holding
Hong Kong
+$34.3M

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$23.8M
2
DTC
Deep Track Capital
Connecticut
-$23.6M
3
OCA
Octagon Capital Advisors
New York
-$3.12M
4
NCM
Nantahala Capital Management
Connecticut
-$2.08M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFG
51
SVB Financial Group
Texas
$1.78M – – –
Prudential Financial
52
Prudential Financial
New Jersey
$1.57M – – –
PHP
53
Parkman Healthcare Partners
Connecticut
$1.51M +$967K +30,000 New
BFM
54
Boothbay Fund Management
New York
$1.41M +$902K +27,981 New
WMSA
55
Weiss Multi-Strategy Advisers
New York
$1.31M +$347K +10,764 +71%
SSA
56
Schonfeld Strategic Advisors
New York
$1.24M +$793K +24,600 New
Morgan Stanley
57
Morgan Stanley
New York
$1.2M +$767K +23,814 New
MS
58
Maven Securities
Jersey
$1.13M -$80.6K -2,500 -10%
BG
59
Bellevue Group
Switzerland
$847K +$541K +16,800 New
Ensign Peak Advisors
60
Ensign Peak Advisors
Utah
$822K +$525K +16,300 New
State Street
61
State Street
Massachusetts
$729K +$96.7K +3,000 +26%
Balyasny Asset Management
62
Balyasny Asset Management
Illinois
$677K +$433K +13,430 New
PCM
63
Prelude Capital Management
New York
$666K +$425K +13,200 New
UOC
64
UBS O'Connor
Illinois
$616K +$65.3K +2,025 +20%
BM
65
Brandywine Managers
Delaware
$555K +$354K +11,000 New
Bank of America
66
Bank of America
North Carolina
$498K +$264K +8,190 +486%
Temasek Holdings
67
Temasek Holdings
Singapore
$485K +$310K +9,617 New
Fidelity International
68
Fidelity International
Bermuda
$434K +$277K +8,609 New
Geode Capital Management
69
Geode Capital Management
Massachusetts
$393K -$79.5K -2,466 -24%
Barclays
70
Barclays
United Kingdom
$294K +$151K +4,700 +415%
Allianz Asset Management
71
Allianz Asset Management
Germany
$277K +$177K +5,500 New
ACP
72
Acuta Capital Partners
California
$252K +$161K +5,000 New
WU
73
Washington University
Missouri
$215K +$138K +4,274 New
VEA
74
Virtus ETF Advisers
New York
$161K -$10.3K -319 -9%
PMAM
75
Picton Mahoney Asset Management
Ontario, Canada
$116K +$74.8K +2,320 New
1 2
3
4

GPCR Hedge Fund Activity: Q3 2023 in Review

84 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Structure Therapeutics (GPCR) for Q3 2023, worth a combined $1.64B — up 135% from $699M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new GPCR positions and 6 closed out — a net gain of 36 holders — while 29 added to existing stakes and 6 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $64.9M. The largest seller was Monashee Investment Management, cutting an estimated $23.8M.

  • 84 institutional investors held Structure Therapeutics (GPCR) as of Q3 2023, up from 48 in Q2 2023.
  • Funds reported $1.64B of Structure Therapeutics stock for Q3 2023, up 135% quarter-over-quarter.
  • 42 funds opened new Structure Therapeutics positions in Q3 2023 and 6 closed out, a net change of +36 holders.
  • The largest Structure Therapeutics buyer in Q3 2023 was Janus Henderson Group, an estimated $64.9M added.
  • The largest Structure Therapeutics seller in Q3 2023 was Monashee Investment Management, an estimated $23.8M sold.

Based on aggregated 13F filings for Q3 2023.